Revolution Medicines (RVMD) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to -$76.9 million.
- Revolution Medicines' Other Gross PP&E Adjustments fell 15361.62% to -$76.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.9 million, marking a year-over-year decrease of 15361.62%. This contributed to the annual value of -$73.0 million for FY2024, which is 5721.45% down from last year.
- Revolution Medicines' Other Gross PP&E Adjustments amounted to -$76.9 million in Q3 2025, which was down 15361.62% from -$58.8 million recorded in Q2 2025.
- Revolution Medicines' 5-year Other Gross PP&E Adjustments high stood at $8.4 million for Q1 2023, and its period low was -$76.9 million during Q3 2025.
- Over the past 5 years, Revolution Medicines' median Other Gross PP&E Adjustments value was -$30.3 million (recorded in 2024), while the average stood at -$33.0 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 12401.55% in 2023, then plummeted by 52441.69% in 2024.
- Over the past 5 years, Revolution Medicines' Other Gross PP&E Adjustments (Quarter) stood at -$41.2 million in 2021, then rose by 29.57% to -$29.0 million in 2022, then crashed by 60.26% to -$46.5 million in 2023, then plummeted by 57.21% to -$73.0 million in 2024, then fell by 5.23% to -$76.9 million in 2025.
- Its last three reported values are -$76.9 million in Q3 2025, -$58.8 million for Q2 2025, and -$67.7 million during Q1 2025.